Apoptosis in Leukemic Cells Induced by Anti-proliferative Coumarin Isolated from the Stem Bark of Fraxinus rhynchophylla

Journal of Microbiology and Biotechnology
Beom Zoo LeeHee Min Yoo

Abstract

Esculetin 6-O-β-D-arabinofuranosyl-(1→6)-β-D-glucopyranoside (EAG) is a coumarin glycoside isolated from the stem bark of Fraxinus rhynchophylla. This study scrutinized the anti-proliferative activity of EAG on blood cancer-derived Jurkat leukemic cells. Cell viability assays in leukemic cancer cells determined that EAG possesses potent anti-proliferative effects. Moreover, treatment with EAG increased the proportion of apoptotic cells, resulted in cell cycle arrest being induced at the subG0/G1 phase, and reduced the proportion of cells present in the S phase. In addition, mitochondrial membrane potential was reduced by EAG in Jurkat cells. Additionally, EAG triggered apoptosis that was mediated by the downregulation of BCL-XL, p-IκBα, and p-p65 expressions in addition to the upregulation of cleaved Caspase 3 and BAX expressions. These findings uncovered that the toxic effect of EAG was mediated by intracellular signal transduction pathways that involved a mechanism in which reactive oxygen species (ROS) were upregulated. Thus, this study concludes that EAG could potentially serve as a therapeutic agent for leukemia.

References

Jan 1, 1996·Phytochemistry·M TakechiY Tanaka
Feb 14, 2006·Current Medicinal Chemistry·Massimo CuriniGiovanni Giannone
Nov 1, 2006·Current Medicinal Chemistry·Manohar V KulkarniChung-Ming Sun
Dec 23, 2006·Fitoterapia·I Kostova, T Iossifova
Mar 8, 2008·International Journal of Cancer. Journal International Du Cancer·Rajaraman SwaminathanViswanathan Shanta
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Robert F FeissnerShey-Shing Sheu
Jul 18, 2009·Methods in Molecular Biology·Donald WlodkowicZbigniew Darzynkiewicz
Apr 8, 2010·Free Radical Research·Geou-Yarh Liou, Peter Storz
Feb 23, 2013·Biochimica Et Biophysica Acta·Gordon M Cragg, David J Newman
Jan 24, 2015·Nature Reviews. Drug Discovery·Alan L HarveyRonald J Quinn
Jan 31, 2015·Nature Reviews. Drug Discovery·Uzma AsgharErik S Knudsen
Dec 19, 2015·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Gordon M Cragg, John M Pezzuto
May 10, 2016·Nature Reviews. Disease Primers·Asim KhwajaDavid C Linch
Jan 20, 2017·Nature Reviews. Disease Primers·Thomas J KippsKanti Rai
Oct 7, 2017·Nature Medicine·Adolfo A Ferrando, Carlos López-Otín
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 1, 2019·Molecular Cancer·Zehuan LiaoNguan Soon Tan
Jun 12, 2019·CA: a Cancer Journal for Clinicians·Kimberly D MillerRebecca L Siegel
Jul 25, 2019·Cancers·Sarmistha MitraNagendra Kumar Kaushik

❮ Previous
Next ❯

Citations

Jan 13, 2021·International Journal of Molecular Sciences·Paula Wróblewska-ŁuczkaJarogniew J Łuszczki

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis